Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Eli Lilly: A Long-Term Growth Stock
Seeking Alpha
Mon, 07/2/12 - 10:42 am
Eli Lilly
diabetes
Bristol-Myers Squibb
Incyte
Merck
Sanofi
Novo Nordisk
Bristol-Myers acquisition a good strategic fit, says Deutsche Bank
Yahoo/Fly on the Wall
Mon, 07/2/12 - 10:41 am
Amylin
M&A
Bristol-Myers Squibb
Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through Bristol-Myers Squibb’s Acquisition of Amylin Pharmaceuticals
Yahoo/BusinessWire
Sat, 06/30/12 - 03:28 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
diabetes
Bristol-Myers To Acquire Diabetes Maker Amylin For $5.3 Billion
Bloomberg
Fri, 06/29/12 - 10:21 pm
Amylin
Bristol-Myers Squibb
M&A
diabetes
Why A Change In A Bristol-Myers Hepatitis C Trial Has Big Implications
Forbes
Fri, 06/29/12 - 09:25 am
hepatitis C
Bristol-Myers Squibb
Gilead
NS5A Inhibitors
daclatasvir
Bristol-Myers Squibb boosts share buyback authorization by $3 billion
Yahoo/AP
Wed, 06/27/12 - 10:16 am
stock buyback
Bristol-Myers Squibb
It's Hard to Sell a Drug Like That
Motley Fool
Wed, 06/27/12 - 10:15 am
Eliquis
Pfizer
Bristol-Myers Squibb
FDA
Novartis, four others weigh Amylin final bids: sources
Reuters
Tue, 06/26/12 - 01:26 pm
Novartis
Amylin
M&A
Bristol-Myers Squibb
AstraZeneca
Merck
Sanofi
Pharmaceuticals Swing; Teva, Pfizer, Bristol-Myers Moving Early
Barron's
Mon, 06/25/12 - 11:04 am
Teva Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Eliquis
Copaxone
FDA delays decision again on Pfizer, Bristol-Myers anticlotting drug with information request
Yahoo/AP
Mon, 06/25/12 - 09:45 am
FDA
Pfizer
Bristol-Myers Squibb
Eliquis
Johnson & Johnson: Charges Could Damage Stock
Seeking Alpha
Fri, 06/22/12 - 10:27 am
JNJ
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Eli Lilly: New Drug Shows Strong Potential
Seeking Alpha
Fri, 06/22/12 - 09:28 am
Eli Lilly
Incyte
baricitinib
Merck
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
rheumatoid arthritis
AstraZeneca Will Soar On 2 New Drugs In 2013
Seeking Alpha
Thu, 06/21/12 - 05:54 pm
AstraZeneca
Bristol-Myers Squibb
JNJ
Eli Lilly
AZD4547
Merck
Sanofi
Dapagliflozin
New Diabetes Drugs May Push Eli Lilly Higher By 2013
Seeking Alpha
Thu, 06/21/12 - 07:39 am
diabetes
Eli Lilly
Astra Zeneca
Bristol-Myers Squibb
Incyte
linagliptin
Novo Nordisk
JNJ
empagliflozin
Boehringer Ingelheim
How Will Zoetis Spinoff Impact Pfizer Stock?
Seeking Alpha
Thu, 06/21/12 - 07:37 am
Zoetis
Pfizer
Bristol-Myers Squibb
JNJ
Merck
Novartis
Bristol Hep C Trial Change Has Big Implications
Pharmalot
Wed, 06/20/12 - 12:31 pm
hepatitis C
Bristol-Myers Squibb
clinical trials
Gilead
NS5A Inhibitors
declatasvir
Merck: Can 5 New Drugs Fill Singulair Gap?
Seeking Alpha
Tue, 06/19/12 - 10:21 am
Merck
Singulair
Pfizer
AstraZeneca
Sanofi
Forest Labs
Bristol-Myers Squibb
suvorexant
Eli Lilly
Bridon
V503
Endocyte
Tredaptive
Otsuka, Bristol-Myers Squibb announce six-year data from SPRYCEL Phase 3 trial on CP-CML
news-medical.net
Sat, 06/16/12 - 02:12 pm
Otsuka
Bristol-Myers Squibb
Sprycel
leukemia
chronic myeloid leukemia
Who Got The Most Buzz At The Diabetes Show?
Pharmalot
Wed, 06/13/12 - 12:05 pm
ADA
diabetes
JNJ
Eli Lilly
Novo Nordisk
Sanofi
Bristol-Myers Squibb
8 Major Healthcare Stocks Yielding At Least 3.9% With P/E Ratios Under 18
Seeking Alpha
Tue, 06/12/12 - 11:03 am
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Eli Lilly
Merck
Novartis
Pfizer
Pages
« first
‹ previous
…
72
73
74
75
76
77
78
79
80
…
next ›
last »